首页> Oncoimmunology> Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8<sup>+</sup> T cell activation in the presence of adjuvant temozolomide.

Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8<sup>+</sup> T cell activation in the presence of adjuvant temozolomide.

导出 LinkOut

翻译打印收藏纠错

第一作者： Serena,Pellegatta

第一单位： Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

作者： Serena,Pellegatta ^[1] ; Marica,Eoli ^[1] ; Valeria,Cuccarini ^[2] ; Elena,Anghileri ^[1] ; Bianca,Pollo ^[3] ; Sara,Pessina ^[1] ; Simona,Frigerio ^[4] ; Maura,Servida ^[1] ; Lucia,Cuppini ^[1] ; Carlo,Antozzi ^[5] ; Stefania,Cuzzubbo ^[1] ; Cristina,Corbetta ^[1] ; Rosina,Paterra ^[1] ; Francesco,Acerbi ^[6] ; Paolo,Ferroli ^[6] ; Francesco,DiMeco ^[7] ; Laura,Fariselli ^[8] ; Eugenio A,Parati ^[4] ; Maria Grazia,Bruzzone ^[2] ; Gaetano,Finocchiaro ^[1]

作者单位： Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. ^[1] Unit of Neuro-Radiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. ^[2] Unit of Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. ^[3] Cell Therapy Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. ^[4] Unit of Neuro-Immunology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. ^[5] Unit of Neurosurgery 2, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. ^[6] Unit of Neurosurgery 1, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. ^[7] Unit of Radiotherapy, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. ^[8]

关键词 Glioblastoma adjuvant chemotherapy dendritic cells immunotherapy natural killer cells

DOI 10.1080/2162402X.2017.1412901

PMID 29632727

发布时间 2021-01-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交